热门资讯> 正文
Inspire Medical重申更新的2025年指南
2025-08-27 05:03
- Inspire Medical Systems (NYSE:INSP) is reaffirming updated 2025 financial guidance it made earlier this month following its Q2 results.
- At that time, the maker of a sleep apnea treatment implant significantly cut its revenue and EPS expectations citing slower than expected uptake of its next-generation device, the Inspire V.
- Revenue guidance is projected at $900M-$910M, while diluted net income per share guidance is expected at $0.40 to $0.50. Consensus is, respectively, $904.45M and $0.86.
More on Inspire Medical Systems
- Inspire Medical: Hiccups For The Sleep Business
- Inspire Medical Systems, Inc. (INSP) Q2 2025 Earnings Call Transcript
- Inspire Medical Systems, Inc. 2025 Q2 - Results - Earnings Call Presentation
- Inspire Medical Systems CFO departs
- Inspire Medical to effect up to $200M stock buyback program
推荐文章
美股机会日报 | 贝特森：美联储主席人选今秋揭晓！英伟达盘后将发财报
一图看懂 | 利润骤降！美团Q2净利同比降低89%至14.9亿元，大幅低于预期
华盛早报 | 苹果最新官宣！秋季发布会定档9月9日；特朗普欲控制美联储“多数席位”以推动降息
美联储首次回应“理事遭开除”事件，特朗普宣称“降息派”很快占上风！
8月27日外盘头条：苹果将于9月9日举行发布会 特朗普与美联储库克斗争加剧 美国政府将入股目光投向国防产业
苹果将于9月9日举行发布会 推出iPhone 17系列和升级版手表
分析：美联储的公信力是重要资产，其受损或代价高昂
美股机会日报 | 大摩改变立场！预计美联储今年降息2次；回声星通信一度飙升逾80%
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
